Skip to main content
logo
Roquefort Therapeutics plc (LON:ROQ)
London flag London · Delayed Price · Currency is GBP · Price in GBX
0.9500
-0.0500 (-5.00%)
Mar 26, 2026, 5:15 PM GMT

Roquefort Therapeutics Financials Overview

Millions GBP. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
---0.2-0
Revenue Growth
------
Gross Profit
---0.020.2--0.01
Operating Income
-0.82-0.82-1.12-1.93-1.63-0.38
Net Income
-3.36-3.36-0.97-1.74-1.62-0.69
Earnings Per Share
-0.22-0.22-0.07-0.13-0.16-0.28
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.080.080.340.542.320.9
Total Debt
--0.4---
Net Cash (Debt)
0.080.08-0.060.542.320.9
Net Cash Growth
----76.87%158.19%-
Net Cash Per Share
0.010.01-0.000.040.220.36

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-0.65-0.65-0.78-1.73-1.58-0.39
Capital Expenditures
----0.05--
Free Cash Flow
-0.65-0.65-0.78-1.79-1.58-0.39
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
---100.00%--
Operating Margin
----966.82%--60121.98%
Pretax Margin
----966.12%--108018.05%
Profit Margin
----872.27%--108018.05%
FCF Margin
----893.79%--60851.65%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
---46.82-11851.65